News
The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...
The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not.
Research shows that NRTIs, antiviral drugs used for HIV, could prevent Alzheimer's by blocking inflammasomes, offering a promising path for drug repurposing.
A new blood test test could determine how far Alzheimer's has progressed and could also help confirm whether another condition is causing a person’s cognitive symptoms.
As the Trump administration makes cuts to federal health agencies, some Alzheimer's experts are worried about the impact on research and patients with the disease.
8d
YouTube on MSNLily flower pendant | Fleur-de-lis | Sparkling and luxurious | jewelry making tutorial 1003Lily flower meaning is purity and fertility. The sweet and innocent beauty of the lily flower has given it the association of fresh life and rebirth. This is a video I remade from the video 6 years ...
Donanemab is only for use in the early stages of Alzheimer’s disease. And for now at least, it comes with a hefty price tag.
In an unprecedented large-scale study, researchers have mapped out the first molecular events that cause harmful protein buildups in the brain of people with Alzheimer's disease. "By measuring the ...
A report from the Alzheimer’s Association says new treatments and blood tests could change how doctors detect and treat the neurodegenerative condition.
The earliest warning signs of Alzheimer's disease include memory loss that impacts your daily functioning, vision and language issues, social withdrawal, and more.
The FDA greenlit marketing for the first blood test to help diagnose Alzheimer’s disease. Experts believe this will increase access to Alzheimer’s detection and reduce reliance on expensive ...
A survey of 1,700 Americans 45 and older found that 79% would want to know if they were in the early stages of Alzheimer's disease.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results